Orbimed Capital GP V LLC
SEC-identified person · CIK 1615374 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Restorbio, Inc. TORC | Director | filed 2020 - 2026 |
| PMV Pharmaceuticals, Inc. PMVP | Director | filed 2020 - 2025 |
| Corvus Pharmaceuticals, Inc. CRVS | Director | filed 2016 - 2025 |
| Tricida, Inc. TCDA | Director | filed 2018 - 2022 |
| Olivia Ventures, Inc. CMPX | Director | filed 2020 - 2022 |
| Zeta Acquisition Corp II WHWK | Director | filed 2017 - 2020 |
| Inspire Medical Systems, Inc. [INSP | Director | filed 2018 - 2020 |
| SI-Bone, Inc. SIBN | Director | filed 2018 - 2018 |
| Armo Biosciences, Inc. ARMO | Director | filed 2018 - 2018 |
| Adaptimmune Therapeutics PLC ADAP] | Director | filed 2016 - 2018 |
| Rhythm Pharmaceuticals, INC. SRYTM | Officer | filed 2017 - 2018 |
| Loxo Oncology, Inc. LOXO | Director | filed 2014 - 2017 |
| Spyre Therapeutics, Inc. SYRE | Officer | filed 2016 - 2017 |
| Nabriva Therapeutics plc NBRV | Director | filed 2016 - 2016 |
| Intellia Therapeutics, Inc. NTLA | Director | filed 2016 - 2016 |
| Dimension Therapeutics, Inc. DMTX | Director | filed 2015 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.